Background: Toric intraocular lenses (IOLs) have been reported to be an effective method of reducing postoperative refractive astigmatism and spectacle dependence following cataract surgery. This study compares a series of patients with low corneal astigmatism implanted with either the AcrySof SA60 spherical IOL or the AcrySof Toric SN60T3 IOL in a quantitative fashion to establish the merit of toric IOLs in these cases.
Methods: A retrospective chart audit was undertaken of 12 patients receiving the AcrySof Toric SN60T3 IOL (1.5 DC, Alcon, Fort Worth) and 10 patients receiving the AcrySof SA60 IOL (Alcon, Fort Worth). Preoperative corneal astigmatism and postoperative refractive astigmatism were recorded and converted into a non-signed Astigmatic Power Vector for statistical analysis. Postoperative vision (uncorrected visual acuity, UCVA) was also recorded for both groups. A statistical analysis was performed to examine for differences in outcomes between groups.
Results: The mean magnitude of the preoperative corneal Astigmatic Power Vector was not significantly different between the groups. The mean magnitude of the postoperative refractive vector was significantly smaller in the AcrySof Toric group. The mean UCVA was significantly better in the AcrySof Toric group compared with the AcrySof group.
Conclusion: The AcrySof Toric IOL provides a significant improvement in postoperative astigmatism and UCVA when compared statistically with its spherical counterpart for patients with low degrees of corneal astigmatism.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1442-9071.2009.02154.x | DOI Listing |
J Clin Med
November 2024
Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.
Phacoemulsification and intraocular lens (IOL) implantation comprise a standard procedure for cataract treatment. However, minimal refractive error remains a determinant of postoperative results. Our study aimed to evaluate the refractive outcomes and the impact of the surgeon's experience and the IOL model on Kosovan and Hungarian patients after cataract surgery.
View Article and Find Full Text PDFPurpose: To assess visual outcomes and stability of lens alignment more than 3 years after implanting either the AT Lisa Tri Toric (Carl Zeiss Meditec) or the Acrysof IQ Restor Toric (Alcon Laboratories, Inc) intraocular lens (IOL).
Methods: Patients who had received either the AT Lisa Tri Toric or the Acrysof IQ Restor Toric IOL were included in the study. The average follow-up period was 5.
Clin Ophthalmol
October 2024
Florida Vision Institute, Stuart, FL, USA.
Purpose: To evaluate patient-reported outcomes of cataract surgery using the Clareon Panoptix and Panoptix Toric trifocal lenses and to compare these to the data collected previously for the AcrySof Panoptix and Panoptix Toric.
Patients And Methods: Prospective, open-label, multicenter analysis of satisfaction, spectacle independence, presence of unwanted side effects, and best-corrected visual acuity among patients undergoing cataract surgery who had been implanted at least 1 month previously with the Clareon PanOptix or PanOptix Toric trifocal IOL bilaterally. Results were compared to outcomes measured two years ago from a similar study with the AcrySof version of the same lens.
Sci Rep
September 2024
Ophthalmology Unit, Agostino Gemelli University Polyclinic, Rome, Italy.
The extended depth-of-focus AcrySof IQ Vivity intraocular lens technology offers promising features for presbyopia management, evaluated in this research in a 6 months real-world setting. Prospective interventional mono-centric study including 40 patients who underwent elective bilateral phacoemulsification. We performed one pre-operative visit (V0) and one evaluation six months post-operatively (V1), evaluating uncorrected and corrected visual acuity for near (UNVA/CNVA), intermediate (UIVA/CIVA) and far (UDVA/UCVA), slit-lamp evaluation, tomography with static pupillometry, endothelial cell count and contrast sensitivity chart.
View Article and Find Full Text PDFInt Ophthalmol
July 2024
LEC Eye Centre, 44-46, Persiaran Greenhill, 30450, Ipoh, Perak, Malaysia.
Purpose: To evaluate the clinical outcomes following bilateral implantation of the AcrySof™ IQ Vivity™ toric extended depth of focus (EDOF) intraocular lens (IOL).
Design: Prospective interventional case series.
Methods: Patients with bilateral significant cataracts and pre-existing corneal astigmatism underwent cataract surgery and implantation with the AcrySof™ IQ Vivity™ toric IOL.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!